Material Theory: Duration and the Serotonin Hypothesis of Depression

Theory, Culture & Society

Volumn 20, Issue 5, 2003, Pages 1-26

  Fraser, Mariam ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

duration; event objects; relations; serotonin hypothesis of depression; time

Indexed keywords

EID: 0142230445     PISSN: 02632764     EISSN: 14603616     Source Type: Journal    
DOI: 10.1177/02632764030205001     Document Type: Article

References (51)

1. Ansell Pearson, Keith (1999) Germinal Life: The Difference and Repetition of Deleuze. London and New York: Routledge.
2. Ashcroft, George (2000) ‘The Receptor Enters Psychiatry (1)’, in D. Healy, The Psychopharmacologists III: Interviews by Dr David Healy. London: Arnold.
3. Azulay, Alison (2001) ‘Regulatory Issues and Generic Names’, pp. 197–252 in T. Blackett and R. Robins (eds) Brand Medicine: The Role of Branding in the Pharmaceutical Industry. Basingstoke, Hampshire and New York: Palgrave.
4. Barad, Karen (1998) ‘Getting Real: Technoscientific Practices and the Materialization of Reality’, differences: A Journal of Feminist Cultural Studies, 10(2): 87-128.
5. Bergson, Henri (1912) An Introduction to Metaphysics, trans. T.E. Hulme. New York and London: The Knickerbocker Press.
6. Bergson, Henri (1998) Creative Evolution. New York: Dover Publications Inc. (First published 1911.)
7. Bowker, Geoffrey, C. and Susan Leigh Star (2000) Sorting Things Out: Classification and Its Consequences. Cambridge, MA and London: MIT Press.
8. Bowman, R.L., P.A. Caulfield and S. Udenfriend (1955) ‘Spectrophotofluorometric Assay in the Visible and Ultraviolet’, Science, 122: 32-33.
9. Brodie, B.B., A. Pletscher and P.A. Shore (1955) ‘Evidence that Serotonin Has a Role in Brain Function’, Science, 122: 968.
10. Cariou, Marie (1999) ‘Bergson: The Keyboards of Forgetting’, pp. 99–117 in J. Mullarky (ed.) The New Bergson. Manchester and New York: Manchester University Press.
11. Carlsson, Arvid (1990) ‘Early Psychopharmacology and the Rise of Modern Brain Research’, Journal of Psychopharmacology, 4(3): 120-126.
12. Carlsson, Arvid and David Wong (1997) ‘A Note on the Discovery of Selective Serotonin Reuptake Inhibitors’, Life Sciences, 61(12): 1203.
13. Cartwright, Lisa (1995) Screening the Body: Tracing Medicine's Visual Culture. Minneapolis and London: University of Minnesota Press.
14. Crane, George (1956) ‘The Psychiatric Side-effects of Iproniazid’, American Journal of Psychiatry, 112: 494-501.
15. Crane, George (1957) ‘Iproniazid (Marsilid) Phosphate, a Therapeutic Agent for Mental Disorders and Debilitating Disease’, Psychiatric Research Reports, 8: 142-154.
16. Dahlström, Annica and Arvid Carlsson (1986) ‘Making Visible the Invisible: Recollections of the First Experiences with the Histochemical Fluorescence Method for Visualization of Tissue Monoamines’, pp. 98–125 in M.J. Parnham and J. Bruinvels (eds) Discoveries in Pharmacology, Volume 3: Pharmacological Methods, Receptors and Chemotherapy. New York: Elsevier Science Publishers.
17. Deleuze, Gilles (1999) ‘Bergson's Conception of Difference’, pp. 42–65 in J. Mullarky (ed.) The New Bergson. Manchester and New York: Manchester University Press.
18. Eli Lilly (2000) ‘Sarafem (fluoxetine) capsules [FDA Approval]’, http://www.cshp.org/CSHP/fda/messages/279.html
19. Fraser, Mariam (2001) ‘The Nature of Prozac’, History of the Human Sciences, 14(3): 57-85.
20. Fraser, Mariam (2002) ‘What is the Matter of Feminist Criticism?’, Economy and Society, 31(4): 606-625.
21. Fraser, Mariam (2003) ‘The Trials of Prozac’, paper presented at Inside Ethics Workshop, Girton College, Cambridge, January.
22. Fraser, Mariam (forthcoming) ‘” We Are in the World and the World Is in Us”: The Clinical Trials of Prozac’, in B. Neilson and M. Bamyeh (eds) Drugs in Motion. Indianapolis: Indiana University Press.
23. Healy, David (1997) The Anti-depressant Era. Cambridge, MA: Harvard University Press.
24. Healy, David (2000) The Psychopharmacologists III: Interviews by David Healy. London: Edward Arnold.
25. Johnston, Paul (2000) ‘Dub, Difference and Repetition: Duration and the Ontology of the Virtual in Seventies Reggae’, unpublished paper. Contact funkfactor4000@yahoo.com for a copy.
26. Keane, Helen (2002) What's Wrong with Addiction? New York: New York University Press.
27. Kerin, Jacinta (1999) ‘The Matter at Hand: Butler, Ontology and the Natural Sciences’, Australian Feminist Studies, 14(29): 91-104.
28. Kline, Nathan, S. (1954) ‘Use of Rauwolfia Serpentina Benth. in Neuropsychiatric Conditions’, Annals New York Academy of Sciences, pp. 107–132.
29. Knorr Cetina, Karen (2001) ‘Postsocial Relations: Theorising Sociality in a Postsocial Environment’, pp. 520–537 in G. Ritzer and B. Smart (eds) Handbook of Social Theory. London: Sage.
30. Kuhn, Thomas (1977) ‘The Function of Measurement in Modern Physical Science’, pp. 178–224 in The Essential Tension: Selected Studies in Scientific Tradition and Change. Chicago, IL and London: University of Chicago Press.
31. Kwinter, Sanford (1998) ‘The Hammer and the Song’, Case Architectural Journal, 48: 31-43.
32. Latour, Bruno (1999) ‘The Historicity of Things’, pp. 145–173 in Pandora's Hope: Essays on the Reality of Science Studies. Cambridge, MA and London: Harvard University Press.
33. Leccese, Arthur P. (1994) ‘Differential Prohibition, Scientific Discourse, and Anorexiant Stimulants’, pp. 108–123 in M.G. Winkler and L.B. Cole (eds) The Good Body: Asceticism in Contemporary Culture. New Haven, CT and London: Yale University Press.
34. Loomer, Harry P., J.C. Saunders and Nathan S. Kline (1957) ‘A Clinical and Pharmacodynamic Evaluation of Iproniazid as a Psychic Energizer’, Psychiatric Research Reports, 8: 129-141.
35. Lury, Celia (1999) ‘Marking Time with Nike: The Illusion of the Durable’, Public Culture, 11(3): 499-526.
36. Massumi, Brian (2002) Parables for the Virtual: Movement, Affect, Sensation. Durham, NC and London: Duke University Press.
37. Mind (2001) Mental Health Statistics 5: The Financial Aspects of Mental Health Problems. London: Mind.
38. Moynihan, Ray (2003) ‘The Making of a Disease: Female Sexual Dysfunction’, British Medical Journal, 326: 45-47. Downloaded on 7 January from http://bmj.com/cgi/content/full/326/7379/45?ijkey=vggM9BCGJ/kQQ
39. O’Connell, Joseph (1993) ‘Metrology: The Creation of Universality by the Circulation of Particulars’, Social Studies of Science, 23: 129-173.
40. Pare, C.M.B. and M. Sandler (1959) ‘A Clinical and Biochemical Study of a Trial of Iproniazid in the Treatment of Depression’, Journal of Neurology, Neurosurgery and Psychiatry, 22: 247-251.
41. Raleigh, Michael J. and Michael T. McGuire (1994) ‘Serotonin, Aggression, and Violence in Vervet Monkeys’, pp. 129–145 in R.D. Masters and M.T. McGuire (eds) The Neurotransmitter Revolution: Serotonin, Social Behavior, and the Law. Carbondale and Edwardsville: Southern Illinois University Press.
42. Rose, Nikolas (2001) ‘The Politics of Life Itself’, Theory, Culture & Society, 18(6): 1-30.
43. Stengers, Isabelle (1997) Power and Invention: Situating Science, trans. Paul Bains. Minneapolis and London: University of Minnesota Press.
44. Stengers, Isabelle (2000) The Invention of Modern Science, trans. Daniel W. Smith. Minneapolis and London: University of Minnesota Press.
45. Udenfriend, S., D.F. Bogdanski and H. Weissbach (1955) ‘Fluorescence Characteristics of 5-hydroxytryptamine (Serotonin)’, Science, 122: 972-973.
46. Vedantam, Shankar (2001) ‘Renamed Prozac Fuels Women's Health Debate’, Washington Post Online, http://www.washingtonpost.com/wp-dyn/articles/A17664-2001April28.html
47. West, E.D. and P.J. Dally (1959) ‘Effects of Iproniazid in Depressive Syndromes’, British Medical Journal, 13 June: 1491-1494.
48. Whitehead, Alfred North (1977) Nature and Life. New York: Greenwood Press.
49. Whitehead, Alfred North (1985) Process and Reality, corrected edn, edited by D.R. Griffin and D.W. Sherbourne. New York: The Free Press.
50. Wise, M. Norton (ed.) (1995) The Values of Precision. Princeton, NJ: Princeton University Press.
51. Woolley, D.W. and E. Shaw (1954) ‘A Biochemical and Pharmacological Suggestion about Certain Mental Disorders’, Science, 119: 587-588.